IP Library Granted Patent US 9,867,648
Granted Patent B2
US 9,867,648 · App. 14/809,826 · Granted Jan 16, 2018

Method and system for consistent, repeatable, and safe cryospray treatment of airway tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,867,648
App. No.
14/809,826
Granted
Jan 16, 2018
Kind
B2
Abstract

A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.

Claims (50)

1. A system comprising:

a cryogen tank in fluid communication with a cryogen delivery device;

one or more adjustable pressure valves configured to adjust a pressure of the cryogen tank in response to a control signal; and

a controller configured to:

receive an indication of a target pressure,

measure the pressure of the cryogen tank during an operation of the cryogen delivery device,

determine whether the measured pressure matches the target pressure,

determine a current rate of change of pressure of the cryogen tank,

adjust the control signal based on the measuring of the pressure of the cryogen tank, the target pressure, the current rate of change of pressure of the cryogen tank, and a pressure history of the cryogen tank; and

adjust the pressure of the cryogen tank towards the target pressure via the one or more adjustable pressure valves in response to the control signal.

2. The system of claim 1 , wherein the controller is configured to determine the target pressure by:

(a) receiving a cooling power measurement indicative of a cooling power of the cryogen delivery device when the cryogen delivery device is delivering a cryogen,

(b) receiving an indication of the cryogen tank pressure when the cryogen delivery device achieves a cooling power corresponding to the cooling power measurement,

(c) identifying that the cooling power measurement matches a target cooling power, and

(d) storing the indicated cryogen tank pressure as the target pressure.

3. The system of claim 2 , further comprising repeating steps (a) and (b) until the cooling power measurement matches the target cooling power.

4. The system of claim 1 , wherein the one or more adjustable pressure valves comprise:

a first valve configured to provide rough reduction in the pressure of the cryogen tank; and

second and third valves configured to control pressure vent and pressure build functions of the cryogen tank.

5. The system of claim 4 , wherein the controller triggers the first valve when the pressure of the cryogen tank is greater than a predetermined threshold amount.

6. The system of claim 4 , wherein the controller triggers the first valve during a fill operation of the cryogen tank.

7. The system of claim 4 , wherein the second and third valves are responsive to a pulse width modulation controller that adjusts its duty cycle based on a control voltage provided by the control signal.

8. The system of claim 4 , wherein the control signal is driven by a proportional-integral-derivative (PID) control algorithm.

9. A system comprising:

a cryospray delivery device operable in a test mode and a normal mode;

a cryogen tank;

an adjustable pressure valve disposed between the cryospray delivery device and the cryogen tank; and

a controller configured to perform the following actions when the cryospray delivery device is operated in the test mode:

measure a cooling power of the cryospray delivery device,

determine a current rate of change of pressure of the cryogen tank,

adjust the adjustable pressure valve in response to the measured cooling power, wherein the controller adjusts the adjustable pressure valve based on the current rate of change of pressure of the cryogen tank, a pressure history, and a pressure set point, and

re-test the system until a desired cooling power is achieved at the cryospray delivery device.

10. The system of claim 9 , wherein the cryospray delivery device comprises a cryospray outlet, and the cooling power is measured at the cryospray outlet.

11. The system of claim 9 , wherein the cryospray delivery device comprises a cryospray delivery catheter.

12. The system of claim 9 , wherein the controller is a pulse width modulation (PWM) controller.

13. The system of claim 9 , wherein the controller is configured to employ a proportional integral derivative (PID) control algorithm.

14. The system of claim 9 , wherein a target cooling power is determined based on information describing a patient and information describing a treatment location.

15. The system of claim 9 , wherein the adjustable pressure valve comprises a valve plunger having a valve plunger position, and the valve plunger position is adjustable in response to a control signal from the controller.

16. The system of claim 9 , wherein the adjustable pressure valve is one of a plurality of proportional solenoid valves.

17. A system comprising:

a cryogen tank in fluid communication with a cryogen delivery device;

one or more adjustable pressure valves configured to adjust a pressure of the cryogen tank in response to a control signal; and

a controller configured to:

identify a target cooling power of the cryogen delivery device,

initiate an operation of the cryogen delivery device,

measure a cooling power of the cryogen delivery device,

determine a current rate of change of pressure of the cryogen tank,

adjust the pressure of the cryogen tank until the cooling power matches the target cooling power, wherein the controller is configured to adjust the pressure based on the current rate of change of pressure of the cryogen tank, a pressure history, and a pressure set point;

record the pressure of the cryogen tank when the cooling power matches the target cooling, and

use the recorded pressure as a target pressure during a future operation of the cryogen delivery device.

Assignments (13)
SECURITY INTEREST Recorded Apr 29, 2024
From: CSA MEDICAL, INC.
To: SYMARK LLC; CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARTZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; TIMOTHY T WEGLICKI RESTATED REVOCABLE TRUST U/A DTD 9-13-2022 AS AMENDED AND RESTATED DURING LIFETIME OF TIMOTHY T WEGLICKI; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 067249/0383 →
NUNC PRO TUNC ASSIGNMENT Recorded Apr 5, 2024
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V.I.P.; SV LIFE SCIENCES FUND V. STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; BHCM CSA MEDICAL, L.L.C.; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P., MR.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER,, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, L.L.C.; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; TIMOTHY T. WEGLICKI RESTATED RECOVABLE TRUST U/A DTD 9-13-2022 AS AMENDED AND RESTATED DURING LIFETIME OF TIMOTHY T WEGLICKI; MELITA, TOM; VICTORIE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 067025/0210 →
SECURITY INTEREST Recorded Jan 25, 2024
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; SV LIFE SCIENCES FUND V, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; LINCOLN, G. RUSSELL; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARTZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; TIMOTHY T WEGLICKI RESTATED REVOCABLE TRUST U/A DTD 9-13- 2022 AS AMENDED AND RESTATED DURING LIFETIME OF TIMOTHY T WEGLICKI; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 066242/0249 →
SECURITY INTEREST Recorded Sep 20, 2023
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; SV LIFE SCIENCES FUND V, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; LINCOLN, G. RUSSELL; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARZ, RICHARD T.; SCHAEFER, STEVEN E.; PECK, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED; DYER, MARK V.
Reel/Frame 064963/0228 →
SECURITY INTEREST Recorded Apr 28, 2023
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; MATHERS ASSOCIATES; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATANIEL T.; HERMANN, TIM VON; SCHWARZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 063474/0974 →
SECURITY INTEREST Recorded Dec 16, 2022
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; MATHERS ASSOCIATES; DISRUPTIVE INNOVATION FUND, LP; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J, JR.; DAVIDSON, MARC S; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL; NATIONAL FINANCIAL SERVICES/ FIDELITY INVESTMENTS CUSTODIAN FBO STEVEN E. SCHAEFER IRA; HERMANN, TIM VON; SCHWARZ, RICHARD T; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 062132/0359 →
SECURITY INTEREST Recorded Nov 3, 2021
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; DISRUPTIVE INNOVATION FUND, LP; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; NATIONAL FINANCIAL SERVICES/ FIDELITY INVESTMENTS CUSTODIAN FBO STEVEN E. SCHAEFER IRA; BROWN, DAVID; HERRMANN, TOM VON; SCHWARZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 058006/0451 →
SECURITY INTEREST Recorded Mar 13, 2020
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; MATHERS ASSOCIATES; DISRUPTIVE INNOVATION FUND, LP; BHCM CSA MEDICAL, LLC; SYMARK LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A; MWK TRUST, MIRIAM WINDER-KELLY TTE; SCHWARZ, RICHARD T; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; MELITA, TOM; VICTOIRE G. RANKIN TRUST
Reel/Frame 052105/0773 →
SECURITY INTEREST Recorded Dec 10, 2019
From: CSA MEDICAL, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 051227/0731 →
SECURITY INTEREST Recorded Oct 22, 2018
From: CSA MEDICAL, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 047261/0311 →
RELEASE OF SECURITY INTEREST Recorded Oct 2, 2018
From: PACIFIC WESTERN BANK
To: CSA MEDICAL, INC.
Reel/Frame 047041/0338 →
SECURITY INTEREST Recorded Feb 21, 2018
From: CSA MEDICAL, INC.
To: PACIFIC WESTERN BANK
Reel/Frame 044985/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2016
From: MULCAHEY, THOMAS; DAVIDSON, MARC; HANLEY, BRIAN M.; SHEETS, ELLEN; FAN, WEI LI
To: CSA MEDICAL, INC.
Reel/Frame 038517/0166 →